Index in Focus: China A50
The markets seem to be willing to look past the bout of Covid raging through China at the moment. As a result, traders see an opportunity to buy stocks.
Stay in step with market opportunities and get insights, actionable trade ideas and dedicated support.
The markets seem to be willing to look past the bout of Covid raging through China at the moment. As a result, traders see an opportunity to buy stocks.
If China continues to re-open its economy, slowly but surely, then the China A50 may continue to move higher as the economy begins to expand once again.
Poor economic data combined with the constant closing and re-opening of certain areas in China have the China A50 on its heels.
Moderna shares have been under pressure this year as interest around Covid-19 vaccines wanes.
The German ZEW and the continued on again/off again lockdowns in China are contributing to fears of a global slowdown or recession.
China is back and looking to move forward. With some help from the government, the trough in the PMI data may be behind us.
The lockdowns in China have led to weaker manufacturing and services data. Is this just the beginning or is there more to come?
Until confidence returns that prices from China will move higher, Gold may begin trading in a range.
Why the COVID outbreak across the country may well get worse before it gets better...
BioNTech has become a world-renowned name thanks to its Covid-19 vaccine, but how will it perform in 2022 as the pandemic continues to ease?
If it is true, as Boris Johnson predicts, that the Omicron variant can be contained and there won’t be further restrictions or lockdowns, it should make for a bullish Pound
Heading into 2022, major indices face several crosswinds that could threaten their recent winning streak...
Market participants are feeling optimistic at the start of the week, with major indices in Europe rising and US stocks poised to open moderately higher and near record high territory
StoneX Europe Ltd may make third party material available on this website which may contain information included but not limited to the conditions of financial markets. The material is for information purposes only and does not contain, and should not be construed as containing, investment advice and/or investment recommendation and/or an investment research and/or an offer of or solicitation for any transactions in financial instruments; any decision to enter into a specific transaction shall be made by the client following an assessment by him/her of their situation.
StoneX Europe Ltd makes no representation or warranty and assumes no liability as to the accuracy or completeness of the information provided, nor any loss arising from any investment based on a recommendation, forecast or other information supplied. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. We are not under any obligation to update any such material. Any opinion made may be personal to the author and may not reflect the opinion of StoneX Europe Ltd.